To obtain emergency consultation with a medical toxicologist, in the United States, call 1-800-222-1222 for the nearest regional poison control center. Contact information for poison control centers around the world is available at the WHO website and in the UpToDate topic on regional poison control centers (society guideline links). |
Clinical presentation |
Impaired consciousness is the most common presentation; ketamine intoxication may cause a range of central neurologic symptoms, most often depressed mental status, but also possibly mild agitation and hallucinations; mild tachycardia and hypertension often occur |
Massive overdose can cause respiratory depression or apnea |
Laryngospasm and heavy salivation may occur infrequently during intravenous use, even with standard doses; laryngospasm is rare and occurs most often in infants |
Vertical or rotatory nystagmus may occur |
Diagnostic testing |
Diagnosis of ketamine intoxication is based on history and clinical evidence; definitive laboratory testing is typically not available and not routinely indicated |
Obtain fingerstick glucose, acetaminophen and salicylate concentrations, electrocardiogram, and pregnancy test in women of childbearing age |
Management |
Secure airway, breathing, and circulation as necessary |
Laryngospasm and respiratory depression - Generally resolve with noninvasive support (eg, bag-mask ventilation; supplemental oxygen); endotracheal intubation is rarely required
|
Salivation that compromises respirations or interferes with a necessary procedure - Treat with glycopyrrolate (5 mcg/kg, maximum single dose 0.2 mg, may be repeated once every two to three minutes, maximum total dose 0.8 mg) or atropine (0.01 to 0.02 mg/kg, minimum dose 0.1 mg, may be repeated every five minutes, maximum dose 1.2 mg)
|
Psychomotor agitation - Treat with benzodiazepines (eg, intravenous doses of diazepam 0.1 mg/kg or in adults 5 to 10 mg, or lorazepam 0.05 mg/kg or in adults 1 to 2 mg) until the desired level of sedation is achieved
- Butyrophenones (eg, haloperidol, droperidol) and other antipsychotic agents should not be used to treat agitation
|
Disposition |
Once symptoms have resolved, patients with uncomplicated ketamine toxicity may be discharged after a suitable period of observation (approximately six hours) during which they remain asymptomatic |